Vorasidenib
Vorasidenib (AG-881) is a potent, selective and orally bioavailable pan-IDH (isocitrate dehydrogenase) mutant inhibitor for treatment of AML.Blood Cancer Phase 1 Clinical.
Product Specifications
CAS Number
1644545-52-7
Product Name Alternative
AG-881 | AG 881 | AG881
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 125 mg/mL 301.39 mM; H2O : < 0.1 mg/mL
Smiles
C[C@@H] (NC1=NC (C2=NC (Cl) =CC=C2) =NC (N[C@H] (C) C (F) (F) F) =N1) C (F) (F) F
Molecular Formula
C14H13ClF6N6
Molecular Weight
414.74
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
6- (6-chloropyridin-2-yl) -N2, N4-bis ((R) -1,1,1-trifluoropropan-2-yl) -1,3,5-triazine-2,4-diamine
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
